Clinical Trials Browser

Phase 1/2 × Multiple Myeloma × Gene Expression Profiling × Clear all

NCT01155583 2020-11-16

Low-Dose Azacitidine, Lenalidomide, and Low-Dose Dexamethasone in Relapsed or Refractory Multiple Myeloma

Phase 1/2 Completed

45 enrolled 20 charts

Multiple Myeloma

NCT01212952 2020-04-17

Pomalidomide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Completed

50 enrolled 12 charts

Multiple Myeloma